SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding
CEPI to provide up to USD 30 million to support development of MSD's Zaire ebolavirus vaccine Collaboration addresses manufacturing complexity and cold-chain challenges to improve yield and thermostability Partnership aims to expand affordable and sustainable vaccine access in low- and middle-income countries INCHEON, South Korea, Jan. 22, 2026 /PRNewswire/ --...
PAQ Therapeutics Announces Series B Extension, Bringing Total Series B Financing to $77 Million; First Patient Dosed in Phase 1 Trial of PT0511, a Pan-KRAS Degrader
BURLINGTON, Mass., Jan. 22, 2026 /PRNewswire/ -- PAQ Therapeutics, a clinical-stage oncology company developing novel targeted protein degradation therapies for KRAS-driven cancers, today announced the closing of a Series B extension, bringing the company's total Series B financing to $77 million, and the dosing of the first patient in a Phase 1...
BTL Announces Successful Enforcement of Patent Rights Relating to EMFACE® Against WonderFace Device
PRAGUE, Jan. 22, 2026 /PRNewswire/ -- BTL Group, a global leader in medical technologies, today announced the successful resolution of multiple patent infringement proceedings against Lexter Microelectronic Engineering Systems S.L. ("Lexter"), the manufacturer of the WonderFace device. The settlement follows patent infringement litigation initiated by BTL in multiple jurisdictions to protect its...
2026 Japan Prize Laureates Announced
TOKYO, Jan. 22, 2026 /PRNewswire/ -- The Japan Prize Foundation announced the winners of the 2026 Japan Prize on January 21, 2026. Prof. Cynthia Dwork (USA) has received the Japan Prize in the field of Electronics, Information, and Communication. Prof. Shizuo Akira (Japan) and Prof. Zhijian "James" Chen (USA) have received the Japan Prize in the field of Life...
Telangana (India) Sets Global Ambition with Next-Gen Life Sciences Policy 2026-30
Positioning Telangana among the world's top five life sciences clusters by 2030 Targets USD 25 billion in investments Shifts focus from scale-led manufacturing to innovation-driven, value creation DAVOS, Switzerland, Jan. 22, 2026 /PRNewswire/ -- The Government of Telangana, India today unveiled its Next-Gen Life Sciences Policy 2026–30 at the World Economic Forum 2026 in Davos, signalling the State's...
BE BOLD & GLOBAL: BE International Triumphs at Functional Foods for Wellness Awards 2026
BANGKOK, Jan. 22, 2026 /PRNewswire/ -- BE International has achieved a spectacular triple victory at the Functional Foods for Wellness Awards 2026 ceremony, held on 20th January 2026 at the Pullman Bangkok King Power in Bangkok, Thailand. The company was honoured with three prestigious accolades for its flagship BElixz series, recognising SHIRUTO, LIVCORE, and I-VXION as category leaders. This...
Shaklee Announces Leadership Change with Appointment of New Taiwan President
MIAMI and TAIPEI, Jan. 21, 2026 /PRNewswire/ -- Shaklee, a global leader in health and wellness, today announced the appointment of Scarlett Su as President of Shaklee Taiwan, effective immediately. Scarlet brings extensive leadership experience in the direct selling and wellness industries, with a strong track record of driving sustainable growth through high-performance team culture, innovative social...
TraceLink Marks Five Years of Sustained Global Impact Through Corporate Grant Program
From pandemic response to long-term community investment, TraceLink's corporate grants have supported 60 nonprofit organizations worldwide SummaryFrom 2020 through 2025, TraceLink's corporate grant program supported 60 nonprofit organizations worldwide, advancing healthcare access, food security, education, humanitarian relief, and community resilience as an extension of its mission to protect patients and strengthen...
Datasea Pre-Announces Fiscal Year 2026 Second Quarter Results
Gross Profit Increased 278% Year-over-Year with Significant Improvement in Gross Margin BEIJING, Jan. 21, 2026 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a Nevada-based technology company specializing in acoustic high-tech solutions and 5G+AI multimodal digitalization, today pre-announced its unaudited financial results for the second quarter of fiscal year 2026,...
Trisol Medical Announces Positive Results from U.S. Early Feasibility Study of Its Transcatheter Tricuspid Valve Replacement System
Results demonstrate a favorable safety profile and functional improvements in patients with severe tricuspid regurgitation including patients with reduced right ventricle function YOKNEAM, Israel, Jan. 21, 2026 /PRNewswire/ -- Trisol Medical, a clinical-stage medical device company developing a transcatheter tricuspid valve replacement system, today announced positive results from its FDA-approved U.S. Early Feasibility Study evaluating the Trisol Transcatheter Tricuspid...
